Compare · CDNA vs UNH
CDNA vs UNH
Side-by-side comparison of CareDx Inc. (CDNA) and UnitedHealth Group Incorporated (UNH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDNA and UNH operate in Medical Specialities (Health Care), so they compete in similar markets.
- UNH is the larger of the two at $355.98B, about 135.5x CDNA ($2.63B).
- Over the past year, CDNA is up 297.0% and UNH is up 32.0% - CDNA leads by 265.1 points.
- CDNA has been more active in the news (11 items in the past 4 weeks vs 7 for UNH).
- UNH has more recent analyst coverage (25 ratings vs 19 for CDNA).
- Company
- CareDx Inc.
- UnitedHealth Group Incorporated
- Price
- $50.82+6.98%
- $396.55-0.58%
- Market cap
- $2.63B
- $355.98B
- 1M return
- +39.77%
- -5.03%
- 1Y return
- +297.03%
- +31.97%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2014
- News (4w)
- 11
- 7
- Recent ratings
- 19
- 25
CareDx Inc.
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It offers AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; and AlloSure Heart, a dd-cfDNA test to identify underlying cell injury leading to organ rejection. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables precision in HLA typing at a low to intermediate resolution for samples that uses real-time polymerase chain reaction methodology; and TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Ottr, a transplant patient tracking software; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors. CareDx, Inc. has a license agreement with Illumina, Inc. for the distribution, development and commercialization rights to NGS products and technologies; and Cibiltech SAS to commercialize KidneyCare iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in South San Francisco, California.
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Latest CDNA
- Amendment: SEC Form SCHEDULE 13G/A filed by CareDx Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by CareDx Inc.
- SEC Form SCHEDULE 13G filed by CareDx Inc.
- Director Bickerstaff George sold $925,700 worth of shares (20,000 units at $46.28), decreasing direct ownership by 13% to 134,061 units (SEC Form 4)
- Director Cournoyer Christine sold $750,973 worth of shares (16,000 units at $46.94), decreasing direct ownership by 27% to 42,943 units (SEC Form 4)
- Secretary and General Counsel Novack Jeffrey Adam sold $124,349 worth of shares (2,688 units at $46.26) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 106,075 units (SEC Form 4)
- Director Goldberg Michael sold $2,103,497 worth of shares (44,700 units at $47.06), decreasing direct ownership by 42% to 61,738 units (SEC Form 4)
- Secretary and General Counsel Novack Jeffrey Adam covered exercise/tax liability with 2,872 shares, decreasing direct ownership by 3% to 108,763 units (SEC Form 4) (for withholding tax)
- SEC Form 144 filed by CareDx Inc.
- SEC Form 144 filed by CareDx Inc.
Latest UNH
- Chief Executive Officer, Optum Conway Patrick Hugh sold $455,910 worth of shares (1,169 units at $390.00), decreasing direct ownership by 7% to 15,328 units (SEC Form 4)
- UnitedHealthcare Expands Access to Child and Family Behavioral Coaching to 13 Million Commercial Members
- Chief Accounting Officer Stankiewicz Dennis Andrew covered exercise/tax liability with 233 shares, decreasing direct ownership by 2% to 10,058 units (SEC Form 4)
- UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
- SEC Form 10-Q filed by UnitedHealth Group Incorporated
- Chief Executive Officer, Optum Conway Patrick Hugh sold $205,000 worth of shares (500 units at $410.00), decreasing direct ownership by 3% to 16,497 units (SEC Form 4)
- SEC Form SCHEDULE 13G filed by UnitedHealth Group Incorporated
- UnitedHealth Group Partners with UT Health Sciences to Expand Health Hubs to More Communities Across Tennessee
- UnitedHealth upgraded by Robert W. Baird with a new price target
- UnitedHealth Group Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits